-
Product Insights
Corneat Vision Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Corneat Vision Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Corneat Vision Ltd (Corneat Vision) an medical device company with an mission of promote human health, sustainability and equality. The company focuses to create groundbreaking solutions to unmet needs in the areas of ophthalmology and periodontology. The company is headquartered in Ra'anana, Israel. GlobalData's Medical Devices company profile report, “Corneat Vision Ltd Pipeline Insight and Competitive Landscape, 2023" provides...
-
Product Insights
Inspira Technologies Oxy Bhn Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Inspira Technologies Oxy Bhn Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Inspira Technologies Oxy Bhn Ltd (Inspira Technologies) is a novel medical technology company in the respiratory treatment area. The company is developing respiratory care solutions as an alternative to invasive mechanical ventilation to treat respiratory failure. It developed INSPIRA ART system, an augmented respiration technology designed to rebalance patient oxygen saturation levels. This technology potentially allows patients...
-
Product Insights
Net Present Value Model: NexoBrid
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model NexoBrid Drug Details Bromelains (NexoBrid) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – bromelains
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry bromelains Drug Details Bromelains (NexoBrid) is a protein extract derived from the stems of...